TuHURA Biosciences Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Jim Bianco
Chief executive officer
US$1.2m
Total compensation
| CEO salary percentage | 37.5% |
| CEO tenure | no data |
| CEO ownership | 5.5% |
| Management average tenure | no data |
| Board average tenure | no data |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$19m |
| Dec 31 2023 | US$1m | US$464k | -US$29m |
| Dec 31 2022 | US$800k | US$400k | -US$9m |
Compensation vs Market: Jim's total compensation ($USD1.24M) is above average for companies of similar size in the US market ($USD646.00K).
Compensation vs Earnings: Jim's compensation has increased whilst the company is unprofitable.
CEO
Jim Bianco (67 yo)
no data
Tenure
US$1,235,485
Compensation
Dr. James A. Bianco, also known as Jim, M.D., serves as CEO, President & Director of Tuhura Biosciences, Inc (formerly known as Morphogenesis, Inc). He served as Chief Development Officer at Prothex, Inc....